Skip to content
2000
Volume 21, Issue 7
  • ISSN: 1573-3947
  • E-ISSN: 1875-6301

Abstract

Platelets are small anucleated blood cells that play a vital role in preserving the integrity of tissue because of their hemostatic properties. However, through their interactions with leukocytes, they also have important functions in immunological responses and inflammation. Platelets have an impact on the tumor's development and metastasis at different stages of cancer. They promote angiogenesis and metastasis by modifying endothelial activation, improving leukocyte migration to tumor locations, and changing inflammatory conditions. Patients with cancer frequently have aberrant platelet activity, which accelerates the progression of the illness. Tumor cells that penetrate the bloodstream stimulate platelets, which causes the tumor cells to take on a mesenchymal-like phenotype and widen the permeability of the endothelium. As a result, tumor cell-platelet emboli are created. In addition, platelets draw in myeloid cells, shield tumor cells from immunological reactions and shear stress, and aid in their extravasation into distant organs. Ultimately, growth factors derived from platelets help create micrometastatic foci. With an emphasis on current advancements in the area, this review clarifies the intricate mechanisms of platelet activation and their interactions with cancer cells.

Loading

Article metrics loading...

/content/journals/cctr/10.2174/0115733947314845240902070425
2024-09-11
2025-12-05
Loading full text...

Full text loading...

References

  1. ContursiA. SaccoA. GrandeR. DovizioM. PatrignaniP. Platelets as crucial partners for tumor metastasis: From mechanistic aspects to pharmacological targeting.Cell. Mol. Life Sci.201774193491350710.1007/s00018‑017‑2536‑728488110
    [Google Scholar]
  2. SmittenaarC.R. PetersenK.A. StewartK. MoittN. Cancer incidence and mortality projections in the UK until 2035.Br. J. Cancer201611591147115510.1038/bjc.2016.30427727232
    [Google Scholar]
  3. ZhouL. ZhangZ. TianY. LiZ. LiuZ. ZhuS. The critical role of platelet in cancer progression and metastasis.Eur. J. Med. Res.202328138510.1186/s40001‑023‑01342‑w37770941
    [Google Scholar]
  4. DesprésJ.P. Body fat distribution and risk of cardiovascular disease: An update.Circulation2012126101301131310.1161/CIRCULATIONAHA.111.06726422949540
    [Google Scholar]
  5. RothwellP.M. WilsonM. ElwinC.E. NorrvingB. AlgraA. WarlowC.P. MeadeT.W. Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials.Lancet201037697541741175010.1016/S0140‑6736(10)61543‑720970847
    [Google Scholar]
  6. PatrignaniP. PatronoC. Aspirin and Cancer.J. Am. Coll. Cardiol.201668996797610.1016/j.jacc.2016.05.08327561771
    [Google Scholar]
  7. DovizioM. AlbertiS. Guillem-LlobatP. PatrignaniP. Role of platelets in inflammation and cancer: Novel therapeutic strategies.Basic Clin. Pharmacol. Toxicol.2014114111812710.1111/bcpt.1215624118902
    [Google Scholar]
  8. BestM.G. SolN. KooiI. TannousJ. WestermanB.A. RustenburgF. SchellenP. VerschuerenH. PostE. KosterJ. YlstraB. AmezianeN. DorsmanJ. SmitE.F. VerheulH.M. NoskeD.P. ReijneveldJ.C. NilssonR.J.A. TannousB.A. WesselingP. WurdingerT. RNA-Seq of Tumor-Educated Platelets Enables Blood-Based Pan-Cancer, Multiclass, and Molecular Pathway Cancer Diagnostics.Cancer Cell201528566667610.1016/j.ccell.2015.09.01826525104
    [Google Scholar]
  9. NilssonR.J.A. BalajL. HullemanE. van RijnS. PegtelD.M. WalravenM. WidmarkA. GerritsenW.R. VerheulH.M. VandertopW.P. NoskeD.P. SkogJ. WürdingerT. Blood platelets contain tumor-derived RNA biomarkers.Blood2011118133680368310.1182/blood‑2011‑03‑34440821832279
    [Google Scholar]
  10. LiZ. DelaneyM.K. O’BrienK.A. DuX. Signaling during platelet adhesion and activation.Arterioscler. Thromb. Vasc. Biol.201030122341234910.1161/ATVBAHA.110.20752221071698
    [Google Scholar]
  11. SimmonsD.L. BottingR.M. HlaT. Cyclooxygenase isozymes: The biology of prostaglandin synthesis and inhibition.Pharmacol. Rev.200456338743710.1124/pr.56.3.315317910
    [Google Scholar]
  12. RiveraJ. LozanoM.L. Navarro-NúñezL. VicenteV. Platelet receptors and signaling in the dynamics of thrombus formation.Haematologica200994570071110.3324/haematol.2008.00317819286885
    [Google Scholar]
  13. GarraudO. CognasseF. Are Platelets Cells? And if Yes, are They Immune Cells?Front. Immunol.20156FEB7010.3389/fimmu.2015.0007025750642
    [Google Scholar]
  14. LannanK.L. SahlerJ. KimN. SpinelliS.L. MaggirwarS.B. GarraudO. CognasseF. BlumbergN. PhippsR.P. Breaking the mold: Transcription factors in the anucleate platelet and platelet-derived microparticles.Front. Immunol.201564810.3389/fimmu.2015.0004825762994
    [Google Scholar]
  15. PalmbladJ. To give and take — life of a platelet.Blood2009113122617261710.1182/blood‑2009‑01‑19813519299653
    [Google Scholar]
  16. PatrignaniP. PatronoC. Aspirin, platelet inhibition and cancer prevention.Platelets201829877978510.1080/09537104.2018.149210529985750
    [Google Scholar]
  17. GayL.J. Felding-HabermannB. Contribution of platelets to tumour metastasis.Nat. Rev. Cancer201111212313410.1038/nrc300421258396
    [Google Scholar]
  18. HanX. GuoB. LiY. ZhuB. Tissue factor in tumor microenvironment: A systematic review.J. Hematol. Oncol.2014715410.1186/s13045‑014‑0054‑825084809
    [Google Scholar]
  19. AdamsG.N. RosenfeldtL. FrederickM. MillerW. WaltzD. KombrinckK. McElhinneyK.E. FlickM.J. MoniaB.P. RevenkoA.S. PalumboJ.S. Colon Cancer Growth and Dissemination Relies upon Thrombin, Stromal PAR-1, and Fibrinogen.Cancer Res.201575194235424310.1158/0008‑5472.CAN‑15‑096426238780
    [Google Scholar]
  20. QueirozK.C.S. ShiK. DuitmanJ. AbersonH.L. WilminkJ.W. van NoeselC.J.M. RichelD.J. SpekC.A. Protease‐activated receptor‐1 drives pancreatic cancer progression and chemoresistance.Int. J. Cancer2014135102294230410.1002/ijc.2872624436106
    [Google Scholar]
  21. ChenD. AbrahamsJ.M. SmithL.M. McVeyJ.H. LechlerR.I. DorlingA. Regenerative repair after endoluminal injury in mice with specific antagonism of protease activated receptors on CD34+ vascular progenitors.Blood200811184155416410.1182/blood‑2007‑10‑12029518268094
    [Google Scholar]
  22. ShaoB. WahrenbrockM.G. YaoL. DavidT. CoughlinS.R. XiaL. VarkiA. McEverR.P. Carcinoma mucins trigger reciprocal activation of platelets and neutrophils in a murine model of Trousseau syndrome.Blood2011118154015402310.1182/blood‑2011‑07‑36851421860019
    [Google Scholar]
  23. AuwerdaJ. YuanaY. OsantoS. de MaatM. SonneveldP. BertinaR. LeebeekF. Microparticle-associated tissue factor activity and venous thrombosis in multiple myeloma.Thromb. Haemost.20111051142010.1160/TH10‑03‑018721057704
    [Google Scholar]
  24. MelnikovaV.O. Mourad-ZeidanA.A. LevD.C. Bar-EliM. Platelet-activating factor mediates MMP-2 expression and activation via phosphorylation of cAMP-response element-binding protein and contributes to melanoma metastasis.J. Biol. Chem.200628152911292210.1074/jbc.M50868320016306050
    [Google Scholar]
  25. LambertA.W. PattabiramanD.R. WeinbergR.A. Emerging Biological Principles of Metastasis.Cell2017168467069110.1016/j.cell.2016.11.03728187288
    [Google Scholar]
  26. XiongG. ChenJ. ZhangG. WangS. KawasakiK. ZhuJ. ZhangY. NagataK. LiZ. ZhouB.P. XuR. Hsp47 promotes cancer metastasis by enhancing collagen-dependent cancer cell-platelet interaction.Proc. Natl. Acad. Sci. USA202011773748375810.1073/pnas.191195111732015106
    [Google Scholar]
  27. CedervallJ. HamidiA. OlssonA.K. Platelets, NETs and cancer.Thromb. Res.2018164Suppl. 1S148S15210.1016/j.thromres.2018.01.04929703474
    [Google Scholar]
  28. TsubakiharaY. MoustakasA. Epithelial-Mesenchymal Transition and Metastasis under the Control of Transforming Growth Factor β.Int. J. Mol. Sci.20181911367210.3390/ijms1911367230463358
    [Google Scholar]
  29. MassaguéJ. ObenaufA.C. Metastatic colonization by circulating tumour cells.Nature2016529758629830610.1038/nature1703826791720
    [Google Scholar]
  30. GuoY. CuiW. PeiY. XuD. Platelets promote invasion and induce epithelial to mesenchymal transition in ovarian cancer cells by TGF-β signaling pathway.Gynecol. Oncol.2019153363965010.1016/j.ygyno.2019.02.02630928020
    [Google Scholar]
  31. LabelleM. BegumS. HynesR.O. Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis.Cancer Cell201120557659010.1016/j.ccr.2011.09.00922094253
    [Google Scholar]
  32. LoweK.L. Navarro-NunezL. WatsonS.P. Platelet CLEC-2 and podoplanin in cancer metastasis.Thromb. Res.2012129S30S3710.1016/S0049‑3848(12)70013‑022682130
    [Google Scholar]
  33. StoiberD. AssingerA. Platelet-Leukocyte Interplay in Cancer Development and Progression.Cells20209485510.3390/cells904085532244723
    [Google Scholar]
  34. TaoL. ZhangL. PengY. TaoM. LiL. XiuD. YuanC. MaZ. JiangB. Neutrophils assist the metastasis of circulating tumor cells in pancreatic ductal adenocarcinoma.Medicine (Baltimore)20169539e493210.1097/MD.000000000000493227684834
    [Google Scholar]
  35. MiklikovaS. MinarikG. SedlackovaT. PlavaJ. CihovaM. JurisovaS. KalavskaK. KarabaM. BencaJ. SmolkovaB. MegoM. Inflammation-Based Scores Increase the Prognostic Value of Circulating Tumor Cells in Primary Breast Cancer.Cancers (Basel)2020125113410.3390/cancers1205113432369910
    [Google Scholar]
  36. WardM.P.E. E KaneL. A NorrisL. MohamedB.M. KellyT. BatesM. ClarkeA. BradyN. MartinC.M. BrooksR.D. BrooksD.A. SelemidisS. HanniffyS. DixonE.P. A O’TooleS. J O’LearyJ. Platelets, immune cells and the coagulation cascade; friend or foe of the circulating tumour cell?Mol. Cancer20212015910.1186/s12943‑021‑01347‑133789677
    [Google Scholar]
  37. RenJ. HeJ. ZhangH. XiaY. HuZ. LoughranP. BilliarT. HuangH. TsungA. Platelet TLR4-ERK5 Axis Facilitates NET-Mediated Capturing of Circulating Tumor Cells and Distant Metastasis after Surgical Stress.Cancer Res.20218192373238510.1158/0008‑5472.CAN‑20‑322233687949
    [Google Scholar]
  38. RachidiS. MetelliA. RiesenbergB. WuB.X. NelsonM.H. WallaceC. PaulosC.M. RubinsteinM.P. Garrett-MayerE. HennigM. BeardenD.W. YangY. LiuB. LiZ. Platelets subvert T cell immunity against cancer via GARP-TGFβ axis.Sci. Immunol.2017211eaai791110.1126/sciimmunol.aai791128763790
    [Google Scholar]
  39. HaemmerleM. TaylorM.L. GutschnerT. PradeepS. ChoM.S. ShengJ. LyonsY.M. NagarajaA.S. DoodR.L. WenY. MangalaL.S. HansenJ.M. RupaimooleR. GharpureK.M. Rodriguez-AguayoC. YimS.Y. LeeJ.S. IvanC. HuW. Lopez-BeresteinG. WongS.T. KarlanB.Y. LevineD.A. LiuJ. Afshar-KharghanV. SoodA.K. Platelets reduce anoikis and promote metastasis by activating YAP1 signaling.Nat. Commun.20178131010.1038/s41467‑017‑00411‑z28827520
    [Google Scholar]
  40. XuX.R. CarrimN. NevesM.A.D. McKeownT. StrattonT.W. CoelhoR.M.P. LeiX. ChenP. XuJ. DaiX. LiB.X. NiH. Platelets and platelet adhesion molecules: Novel mechanisms of thrombosis and anti-thrombotic therapies.Thromb. J.201614S1Suppl. 12910.1186/s12959‑016‑0100‑627766055
    [Google Scholar]
  41. GongL. MiH.J. ZhuH. ZhouX. YangH. P-selectin-mediated platelet activation promotes adhesion of non-small cell lung carcinoma cells on vascular endothelial cells under flow.Mol. Med. Rep.20125493594210.3892/mmr.2012.76022266541
    [Google Scholar]
  42. PlantureuxL. MègeD. CrescenceL. CarminitaE. RobertS. CointeS. BrouillyN. EzzedineW. Dignat-GeorgeF. DuboisC. Panicot-DuboisL. The Interaction of Platelets with Colorectal Cancer Cells Inhibits Tumor Growth but Promotes Metastasis.Cancer Res.202080229130310.1158/0008‑5472.CAN‑19‑118131727628
    [Google Scholar]
  43. SempleJ.W. ItalianoJ.E.Jr FreedmanJ. Platelets and the immune continuum.Nat. Rev. Immunol.201111426427410.1038/nri295621436837
    [Google Scholar]
  44. HaemmerleM. StoneR.L. MenterD.G. Afshar-KharghanV. SoodA.K. The Platelet Lifeline to Cancer: Challenges and Opportunities.Cancer Cell201833696598310.1016/j.ccell.2018.03.00229657130
    [Google Scholar]
  45. SchumacherD. StrilicB. SivarajK.K. WettschureckN. OffermannsS. Platelet-derived nucleotides promote tumor-cell transendothelial migration and metastasis via P2Y2 receptor.Cancer Cell201324113013710.1016/j.ccr.2013.05.00823810565
    [Google Scholar]
  46. LabelleM. BegumS. HynesR.O. Platelets guide the formation of early metastatic niches.Proc. Natl. Acad. Sci. USA201411130E3053E306110.1073/pnas.141108211125024172
    [Google Scholar]
  47. KerrB.A. McCabeN.P. FengW. ByzovaT.V. Platelets govern pre-metastatic tumor communication to bone.Oncogene201332364319432410.1038/onc.2012.44723069656
    [Google Scholar]
  48. JinD.K. ShidoK. KoppH.G. PetitI. ShmelkovS.V. YoungL.M. HooperA.T. AmanoH. AvecillaS.T. HeissigB. HattoriK. ZhangF. HicklinD.J. WuY. ZhuZ. DunnA. SalariH. WerbZ. HackettN.R. CrystalR.G. LydenD. RafiiS. Cytokine-mediated deployment of SDF-1 induces revascularization through recruitment of CXCR4+ hemangiocytes.Nat. Med.200612555756710.1038/nm140016648859
    [Google Scholar]
  49. BambaceN.M. HolmesC.E. The platelet contribution to cancer progression.J. Thromb. Haemost.20119223724910.1111/j.1538‑7836.2010.04131.x21040448
    [Google Scholar]
  50. SchlesingerM. Role of platelets and platelet receptors in cancer metastasis.J. Hematol. Oncol.201811112510.1186/s13045‑018‑0669‑230305116
    [Google Scholar]
  51. SchwertzH. RowleyJ.W. TolleyN.D. CampbellR.A. WeyrichA.S. Assessing Protein Synthesis by Platelets.Platelets and MegakaryocytesBerlin, HeidelbergSpringer Link201210.1007/978‑1‑61779‑307‑3_11
    [Google Scholar]
  52. Ho-Tin-NoéB. CarboC. DemersM. CifuniS.M. GoergeT. WagnerD.D. Innate immune cells induce hemorrhage in tumors during thrombocytopenia.Am. J. Pathol.200917541699170810.2353/ajpath.2009.09046019729481
    [Google Scholar]
  53. CohenJD LiL WangY ThoburnC AfsariB DanilovaL Detection and localization of surgically resectable cancers with a multi-analyte blood test.Science20183596378926930
    [Google Scholar]
  54. ContursiA. GrandeR. DovizioM. BrunoA. FulloneR. PatrignaniP. Platelets in cancer development and diagnosis.Biochem. Soc. Trans.20184661517152710.1042/BST2018015930420412
    [Google Scholar]
  55. SabrkhanyS. KuijpersM.J.E. KnolJ.C. Olde DaminkS.W.M. DingemansA.M.C. VerheulH.M. PiersmaS.R. PhamT.V. GriffioenA.W. oude EgbrinkM.G.A. JimenezC.R. Exploration of the platelet proteome in patients with early-stage cancer.J. Proteomics2018177657410.1016/j.jprot.2018.02.01129432918
    [Google Scholar]
  56. PetersonJ.E. ZurakowskiD. ItalianoJ.E.Jr MichelL.V. ConnorsS. OenickM. D’AmatoR.J. KlementG.L. FolkmanJ. VEGF, PF4 and PDGF are elevated in platelets of colorectal cancer patients.Angiogenesis201215226527310.1007/s10456‑012‑9259‑z22402885
    [Google Scholar]
  57. BurkhartJ.M. GambaryanS. WatsonS.P. JurkK. WalterU. SickmannA. HeemskerkJ.W.M. ZahediR.P. What can proteomics tell us about platelets?Circ. Res.201411471204121910.1161/CIRCRESAHA.114.30159824677239
    [Google Scholar]
  58. LomnytskaM. PintoR. BeckerS. EngströmU. GustafssonS. BjörklundC. TemplinM. BergstrandJ. XuL. WidengrenJ. EpsteinE. FranzénB. AuerG. Platelet protein biomarker panel for ovarian cancer diagnosis.Biomark. Res.201861210.1186/s40364‑018‑0118‑y29344361
    [Google Scholar]
  59. FutakuchiM. OgawaK. SanoM. TamanoS. TakeshitaF. ShiraiT. Suppression of lung metastasis by aspirin but not indomethacin in an in vivo model of chemically induced hepatocellular carcinoma.Jpn. J. Cancer Res.200293101175118110.1111/j.1349‑7006.2002.tb01220.x12417048
    [Google Scholar]
  60. JacobsC.D. ChunS.G. YanJ. XieX.J. PistenmaaD.A. HannanR. LotanY. RoehrbornC.G. ChoeK.S. KimD.W.N. Aspirin improves outcome in high risk prostate cancer patients treated with radiation therapy.Cancer Biol. Ther.201415669970610.4161/cbt.2855424658086
    [Google Scholar]
  61. ShiaoJ. ThomasK.M. RahimiA.S. RaoR. YanJ. XieX.J. DaSilvaM. SpanglerA. LeitchM. WooldridgeR. RiversA. FarrD. HaleyB. KimD.W.N. Aspirin/antiplatelet agent use improves disease-free survival and reduces the risk of distant metastases in Stage II and III triple-negative breast cancer patients.Breast Cancer Res. Treat.2017161346347110.1007/s10549‑016‑4081‑828005245
    [Google Scholar]
  62. HolmesM.D. ChenW.Y. LiL. HertzmarkE. SpiegelmanD. HankinsonS.E. Aspirin intake and survival after breast cancer.J. Clin. Oncol.20102891467147210.1200/JCO.2009.22.791820159825
    [Google Scholar]
  63. HuaH. ZhangH. KongQ. WangJ. JiangY. Complex roles of the old drug aspirin in cancer chemoprevention and therapy.Med. Res. Rev.201939111414510.1002/med.2151429855050
    [Google Scholar]
  64. Guillem-LlobatP. DovizioM. BrunoA. RicciottiE. CufinoV. SaccoA. GrandeR. AlbertiS. ArenaV. CirilloM. PatronoC. FitzGeraldG.A. SteinhilberD. SgambatoA. PatrignaniP. Aspirin prevents colorectal cancer metastasis in mice by splitting the crosstalk between platelets and tumor cells.Oncotarget2016722324623247710.18632/oncotarget.865527074574
    [Google Scholar]
  65. RothwellP.M. FowkesF.G.R. BelchJ.F.F. OgawaH. WarlowC.P. MeadeT.W. Effect of daily aspirin on long-term risk of death due to cancer: Analysis of individual patient data from randomised trials.Lancet20113779759314110.1016/S0140‑6736(10)62110‑121144578
    [Google Scholar]
  66. BattinelliE.M. MarkensB.A. KulenthirarajanR.A. MachlusK.R. FlaumenhaftR. ItalianoJ.E.Jr Anticoagulation inhibits tumor cell–mediated release of platelet angiogenic proteins and diminishes platelet angiogenic response.Blood2014123110111210.1182/blood‑2013‑02‑48501124065244
    [Google Scholar]
  67. SitiaG. AiolfiR. Di LuciaP. MainettiM. FiocchiA. MingozziF. EspositoA. RuggeriZ.M. ChisariF.V. IannaconeM. GuidottiL.G. Antiplatelet therapy prevents hepatocellular carcinoma and improves survival in a mouse model of chronic hepatitis B.Proc. Natl. Acad. Sci. USA201210932E2165E217210.1073/pnas.120918210922753481
    [Google Scholar]
  68. AmirkhosraviA. MousaS.A. AmayaM. BlaydesS. DesaiH. MeyerT. FrancisJ.L. Inhibition of tumor cell-induced platelet aggregation and lung metastasis by the oral GpIIb/IIIa antagonist XV454.Thromb. Haemost.200390354955412958625
    [Google Scholar]
  69. BoukercheH. Berthier-VergnesO. TaboneE. DoréJ.F. LeungL.L. McGregorJ.L. Platelet-melanoma cell interaction is mediated by the glycoprotein IIb- IIIa complex.Blood198974265866310.1182/blood.V74.2.658.6582752140
    [Google Scholar]
  70. DovizioM. MaierT.J. AlbertiS. Di FrancescoL. MarcantoniE. MünchG. JohnC.M. SuessB. SgambatoA. SteinhilberD. PatrignaniP. Pharmacological inhibition of platelet-tumor cell cross-talk prevents platelet-induced overexpression of cyclooxygenase-2 in HT29 human colon carcinoma cells.Mol. Pharmacol.2013841254010.1124/mol.113.08498823580446
    [Google Scholar]
  71. FreeS.R. CarrawayK.L. Platelets in Hematogenous Breast Cancer Metastasis: Partners in Crime.Breast Cancer.AustraliaExon Publications202210111410.36255/exon‑publications‑breast‑cancer‑platelets
    [Google Scholar]
  72. ElaskalaniO. BerndtM. FalascaM. MetharomP. Targeting Platelets for the Treatment of Cancer.Cancers (Basel)2017979410.3390/cancers907009428737696
    [Google Scholar]
  73. StoletovK. BeattyP.H. LewisJ.D. Novel therapeutic targets for cancer metastasis.Expert Rev. Anticancer Ther.20202029710910.1080/14737140.2020.171849631997674
    [Google Scholar]
  74. LiaoK ZhangX LiuJ TengF HeY ChengJ The role of platelets in the regulation of tumor growth and metastasis: The mechanisms and targeted therapy.MedComm202345e35010.1002/mco2.350
    [Google Scholar]
/content/journals/cctr/10.2174/0115733947314845240902070425
Loading
/content/journals/cctr/10.2174/0115733947314845240902070425
Loading

Data & Media loading...


  • Article Type:
    Review Article
Keyword(s): anti-platelet drugs; cancer; growth factors; metastasis; platelets; Tumor
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test